Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Residual tissue repositories as a resource for population-based cancer proteomic studies.

Piehowski PD, Petyuk VA, Sontag RL, Gritsenko MA, Weitz KK, Fillmore TL, Moon J, Makhlouf H, Chuaqui RF, Boja ES, Rodriguez H, Lee JSH, Smith RD, Carrick DM, Liu T, Rodland KD.

Clin Proteomics. 2018 Aug 3;15:26. doi: 10.1186/s12014-018-9202-4. eCollection 2018.

2.

The effects of frozen tissue storage conditions on the integrity of RNA and protein.

Auer H, Mobley JA, Ayers LW, Bowen J, Chuaqui RF, Johnson LA, Livolsi VA, Lubensky IA, McGarvey D, Monovich LC, Moskaluk CA, Rumpel CA, Sexton KC, Washington MK, Wiles KR, Grizzle WE, Ramirez NC.

Biotech Histochem. 2014 Oct;89(7):518-28. doi: 10.3109/10520295.2014.904927. Epub 2014 May 6.

3.

Decrease in CD8+ lymphocyte number and altered cytokine profile in human prostate cancer.

Gannot G, Richardson AM, Rodriguez-Canales J, Pinto PA, Merino MJ, Chuaqui RF, Gillespie JW, Emmert-Buck MR.

Am J Cancer Res. 2011;1(1):120-127. Epub 2010 Nov 10.

4.

Effect of immunohistochemistry on molecular analysis of tissue samples: implications for microdissection technologies.

Tangrea MA, Mukherjee S, Gao B, Markey SP, Du Q, Armani M, Kreitman MS, Rosenberg AM, Wallis BS, Eberle FC, Duncan FC, Hanson JC, Chuaqui RF, Rodriguez-Canales J, Emmert-Buck MR.

J Histochem Cytochem. 2011 Jun;59(6):591-600. doi: 10.1369/0022155411404704. Epub 2011 Mar 23.

5.

Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma.

Mukherjee S, Roth MJ, Dawsey SM, Yan W, Rodriguez-Canales J, Erickson HS, Hu N, Goldstein AM, Taylor PR, Richardson AM, Tangrea MA, Chuaqui RF, Emmert-Buck MR.

J Transl Med. 2010 Oct 5;8:91. doi: 10.1186/1479-5876-8-91.

6.

Influence of hypoxia induced by minimally invasive prostatectomy on gene expression: implications for biomarker analysis.

Erickson HS, Josephson JW, Vira M, Albert PS, Gillespie JW, Rodriguez-Canales J, Pinto PA, Chuaqui RF, Emmert-Buck MR, Coleman JA.

Am J Transl Res. 2010 Apr 10;2(3):210-22.

7.

High throughput screening of normal and neoplastic tissue samples.

Erickson HS, Gannot G, Tangrea MA, Chuaqui RF, Gillespie JW, Emmert-Buck MR.

Comb Chem High Throughput Screen. 2010 Mar;13(3):253-67. Review.

PMID:
20015016
8.

Identification of EpCAM as a molecular target of prostate cancer stroma.

Mukherjee S, Richardson AM, Rodriguez-Canales J, Ylaya K, Erickson HS, Player A, Kawasaki ES, Pinto PA, Choyke PL, Merino MJ, Albert PS, Chuaqui RF, Emmert-Buck MR.

Am J Pathol. 2009 Dec;175(6):2277-87. doi: 10.2353/ajpath.2009.090013. Epub 2009 Oct 22.

9.

Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples.

Erickson HS, Albert PS, Gillespie JW, Rodriguez-Canales J, Marston Linehan W, Pinto PA, Chuaqui RF, Emmert-Buck MR.

Nat Protoc. 2009;4(6):902-22. doi: 10.1038/nprot.2009.61. Epub 2009 May 21.

10.

Global expression analysis of prostate cancer-associated stroma and epithelia.

Richardson AM, Woodson K, Wang Y, Rodriguez-Canales J, Erickson HS, Tangrea MA, Novakovic K, Gonzalez S, Velasco A, Kawasaki ES, Emmert-Buck MR, Chuaqui RF, Player A.

Diagn Mol Pathol. 2007 Dec;16(4):189-97.

PMID:
18043281
11.

Assessment of normalization strategies for quantitative RT-PCR using microdissected tissue samples.

Erickson HS, Albert PS, Gillespie JW, Wallis BS, Rodriguez-Canales J, Linehan WM, Gonzalez S, Velasco A, Chuaqui RF, Emmert-Buck MR.

Lab Invest. 2007 Sep;87(9):951-62. Epub 2007 Jul 23.

12.

Layered peptide array for multiplex immunohistochemistry.

Gannot G, Tangrea MA, Erickson HS, Pinto PA, Hewitt SM, Chuaqui RF, Gillespie JW, Emmert-Buck MR.

J Mol Diagn. 2007 Jul;9(3):297-304.

13.

Layered peptide arrays: a diverse technique for antibody screening of clinical samples.

Gannot G, Tangrea MA, Chuaqui RF, Gillespie JW, Emmert-Buck MR.

Ann N Y Acad Sci. 2007 Mar;1098:451-3.

PMID:
17435150
14.

Identification of a unique epigenetic sub-microenvironment in prostate cancer.

Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW, Merino MJ, Libutti SK, Woodson KG, Emmert-Buck MR, Chuaqui RF.

J Pathol. 2007 Mar;211(4):410-9.

PMID:
17278115
15.

Layered expression scanning: multiplex molecular analysis of diverse life science platforms.

Gannot G, Tangrea MA, Richardson AM, Flaig MJ, Hewitt SM, Marcus EM, Emmert-Buck MR, Chuaqui RF.

Clin Chim Acta. 2007 Feb;376(1-2):9-16. Epub 2006 Aug 11. Review.

PMID:
16996046
16.

Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer.

Grover AC, Tangrea MA, Woodson KG, Wallis BS, Hanson JC, Chuaqui RF, Gillespie JW, Erickson HS, Bonner RF, Pohida TJ, Emmert-Buck MR, Libutti SK.

J Transl Med. 2006 Mar 2;4:13.

17.

Gene promoter methylation in prostate tumor-associated stromal cells.

Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG.

J Natl Cancer Inst. 2006 Feb 15;98(4):255-61.

PMID:
16478744
18.

Layered peptide arrays: high-throughput antibody screening of clinical samples.

Gannot G, Tangrea MA, Gillespie JW, Erickson HS, Wallis BS, Leakan RA, Knezevic V, Hartmann DP, Chuaqui RF, Emmert-Buck MR.

J Mol Diagn. 2005 Oct;7(4):427-36.

19.

Molecular alterations in primary prostate cancer after androgen ablation therapy.

Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH, González S, Velasco A, Linehan WM, Matusik RJ, Price DK, Figg WD, Emmert-Buck MR, Chuaqui RF.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6823-34.

20.

Novel proteomic approaches for tissue analysis.

Tangrea MA, Wallis BS, Gillespie JW, Gannot G, Emmert-Buck MR, Chuaqui RF.

Expert Rev Proteomics. 2004 Aug;1(2):185-92. Review.

PMID:
15966813
21.

Histomathematical analysis of clinical specimens: challenges and progress.

Gannot G, Gillespie JW, Chuaqui RF, Tangrea MA, Linehan WM, Emmert-Buck MR.

J Histochem Cytochem. 2005 Feb;53(2):177-85.

PMID:
15684330
22.

Expression microdissection: operator-independent retrieval of cells for molecular profiling.

Tangrea MA, Chuaqui RF, Gillespie JW, Ahram M, Gannot G, Wallis BS, Best CJ, Linehan WM, Liotta LA, Pohida TJ, Bonner RF, Emmert-Buck MR.

Diagn Mol Pathol. 2004 Dec;13(4):207-12.

PMID:
15538110
23.

Comparison of snap freezing versus ethanol fixation for gene expression profiling of tissue specimens.

Perlmutter MA, Best CJ, Gillespie JW, Gathright Y, González S, Velasco A, Linehan WM, Emmert-Buck MR, Chuaqui RF.

J Mol Diagn. 2004 Nov;6(4):371-7.

24.

Molecular profiling of cancer.

Gillespie JW, Gannot G, Tangrea MA, Ahram M, Best CJ, Bichsel VE, Petricoin EF, Emmert-Buck MR, Chuaqui RF.

Toxicol Pathol. 2004 Mar-Apr;32 Suppl 1:67-71. Review.

PMID:
15209405
25.

Layered expression scanning: multiplex analysis of RNA and protein gels.

Tangrea MA, Flaig MJ, Ramesh A, Best CJ, Baibakov GV, Hewitt SM, Mitchell CD, Hartmann DP, Knezevic V, Emmert-Buck MR, Chuaqui RF.

Biotechniques. 2003 Dec;35(6):1280-5.

26.

Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis.

Best CJ, Leiva IM, Chuaqui RF, Gillespie JW, Duray PH, Murgai M, Zhao Y, Simon R, Kang JJ, Green JE, Bostwick DG, Linehan WM, Emmert-Buck MR.

Diagn Mol Pathol. 2003 Jun;12(2):63-70.

PMID:
12766610
27.

Post-analysis follow-up and validation of microarray experiments.

Chuaqui RF, Bonner RF, Best CJ, Gillespie JW, Flaig MJ, Hewitt SM, Phillips JL, Krizman DB, Tangrea MA, Ahram M, Linehan WM, Knezevic V, Emmert-Buck MR.

Nat Genet. 2002 Dec;32 Suppl:509-14. Review.

PMID:
12454646
28.
29.

Evaluation of non-formalin tissue fixation for molecular profiling studies.

Gillespie JW, Best CJ, Bichsel VE, Cole KA, Greenhut SF, Hewitt SM, Ahram M, Gathright YB, Merino MJ, Strausberg RL, Epstein JI, Hamilton SR, Gannot G, Baibakova GV, Calvert VS, Flaig MJ, Chuaqui RF, Herring JC, Pfeifer J, Petricoin EF, Linehan WM, Duray PH, Bova GS, Emmert-Buck MR.

Am J Pathol. 2002 Feb;160(2):449-57.

30.

Proteomic analysis of human prostate cancer.

Ahram M, Best CJ, Flaig MJ, Gillespie JW, Leiva IM, Chuaqui RF, Zhou G, Shu H, Duray PH, Linehan WM, Raffeld M, Ornstein DK, Zhao Y, Petricoin EF 3rd, Emmert-Buck MR.

Mol Carcinog. 2002 Jan;33(1):9-15.

PMID:
11807953
31.

Molecular profiling of clinical tissues specimens: feasibility and applications.

Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV, Prang C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD, Waterston RH.

J Mol Diagn. 2000 May;2(2):60-6. Review. No abstract available.

32.

Molecular profiling of clinical tissue specimens: feasibility and applications.

Emmert-Buck MR, Strausberg RL, Krizman DB, Bonaldo MF, Bonner RF, Bostwick DG, Brown MR, Buetow KH, Chuaqui RF, Cole KA, Duray PH, Englert CR, Gillespie JW, Greenhut S, Grouse L, Hillier LW, Katz KS, Klausner RD, Kuznetzov V, Lash AE, Lennon G, Linehan WM, Liotta LA, Marra MA, Munson PJ, Ornstein DK, Prabhu VV, Prange C, Schuler GD, Soares MB, Tolstoshev CM, Vocke CD, Waterston RH.

Am J Pathol. 2000 Apr;156(4):1109-15. Review. No abstract available.

33.

Histopathology and molecular biology of ovarian epithelial tumors.

Chuaqui RF, Cole KA, Emmert-Buck MR, Merino MJ.

Ann Diagn Pathol. 1998 Jun;2(3):195-207. Review.

PMID:
9845739
34.

cDNA sequencing and analysis of POV1 (PB39): a novel gene up-regulated in prostate cancer.

Cole KA, Chuaqui RF, Katz K, Pack S, Zhuang Z, Cole CE, Lyne JC, Linehan WM, Liotta LA, Emmert-Buck MR.

Genomics. 1998 Jul 15;51(2):282-7.

PMID:
9722952
35.

General mechanisms of metastasis.

Woodhouse EC, Chuaqui RF, Liotta LA.

Cancer. 1997 Oct 15;80(8 Suppl):1529-37. Review.

PMID:
9362419
36.

Identification of a novel transcript up-regulated in a clinically aggressive prostate carcinoma.

Chuaqui RF, Englert CR, Strup SE, Vocke CD, Zhuang Z, Duray PH, Bostwick DG, Linehan WM, Liotta LA, Emmert-Buck MR.

Urology. 1997 Aug;50(2):302-7.

PMID:
9255310
37.

Molecular genetic events in the development and progression of ovarian cancer in humans.

Chuaqui RF, Zhuang Z, Merino MJ.

Mol Med Today. 1997 May;3(5):207-13. Review.

PMID:
9176883
38.

Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ.

Am J Pathol. 1997 Jan;150(1):297-303.

39.

Construction of a representative cDNA library from prostatic intraepithelial neoplasia.

Krizman DB, Chuaqui RF, Meltzer PS, Trent JM, Duray PH, Linehan WM, Liotta LA, Emmert-Buck MR.

Cancer Res. 1996 Dec 1;56(23):5380-3.

40.

Laser capture microdissection.

Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA.

Science. 1996 Nov 8;274(5289):998-1001.

PMID:
8875945
41.

Genetic analysis of synchronous mucinous tumors of the ovary and appendix.

Chuaqui RF, Zhuang Z, Emmert-Buck MR, Bryant BR, Nogales F, Tavassoli FA, Merino MJ.

Hum Pathol. 1996 Feb;27(2):165-71.

PMID:
8617458
42.

Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas.

Chuaqui RF, Sanz-Ortega J, Vocke C, Linehan WM, Sanz-Esponera J, Zhuang Z, Emmert-Buck MR, Merino MJ.

Cancer Res. 1995 Nov 1;55(21):4995-8.

Supplemental Content

Loading ...
Support Center